You are hereList of Publications

List of Publications


Diapositiva 18



Latest articles published in indexed journals

J

• Garcia-Serna R, Mestres J. Anticipating drug side effects by comparative pharmacology. Expert Opin Drug Metab Toxicol, 2010; in press.

• Vidal D, Mestres J. In silico receptrome screening of antipsychotic drugs. Mol Inf. 2010; in press.

• Matos S, Arrais JP, Maia-Rodriguez J, Oliveira JL. Concept-based query expansion for retrieving gene related publications from MEDLINE. BMC Bioinformatics. 2010; 11:212.

Avillach P, Mougin F, Joubert M, Thiessard F, Pariente A, Dufour JC, Trifirò G, Polimeni G, Catania MA, Giaquinto C, Mazzaglia G, Baio G, Herings R, Gini R,Hippisley-Cox J, Molokhia M, Pedersen L, Fourrier-Réglat A, Sturkenboom M, Fieschi M. A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project. Stud Health Technol Inform. 2009;150:190-4.

• Tzoulaki I & Molokhia M, Curcin V, Little MP, Millett CJ, Ng A, Hughes RI, Khunti K, Wilkins MR, Majeed A, Elliott P. Risk of cardiovascular disease among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ. 2009 Dec 3; 339: b4731. doi: 10.1136/bmj.b4731. PubMed PMID: 19959591.

• Schuemie MJ, Kang N, Hekkelman ML, Kors JA. GeneE: Gene and protein query expansion with disambiguation. Bioinformatics. 2009 Oct 16.

• Trifiro G, Fourrier-Reglat A, Sturkenboom MC, Díaz Acedo C, Van Der Lei J. The EU-ADR Project: Preliminary Results and Perspective. Stud Health Technol Inform. 2009; 148:43-9.

• Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: systematic review. Clin Epidemiology. 2009 May 27; 1:75–92.

• Trifirò G, Pariente A, Coloma PM, Kors JA, Polimeni G, Miremont-Salamé G, Catania MA, Salvo F, David A, Moore N, Caputi AP, Sturkenboom M, Molokhia M, Hippisley-Cox J, Acedo CD, van der Lei J, Fourrier-Reglat A; EU-ADR group. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1176-84.

• Bauer-Mehren A, Furlong LI, Sanz F. Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol. 2009;5:290. Epub 2009 Jul 28. PubMed PMID: 19638971; PubMed Central PMCID: PMC2724977.

• Bauer-Mehren A, Furlong LI and Sanz F. Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Molecular Systems Biology. 2009, 5:290.Bauer-Mehren A, Furlong L, Rautschka M, and Sanz F. From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways. BMC Bioinformatics 2009, 10 (Suppl 8): S6.

• Molokhia M, Pathak A, Lapeyre-Mestre M, Caturla M, Montastruc JL, L'Association Française des Centres Régionaux de Pharmacovigilance (CRPV) and McKeigue P. Case ascertainment and estimated incidence of drug-induced long QT syndrome: study in southwest France. Br J Clin Pharmacol. 2008 Jul 16; 66(3): 386-395. DOI:10.1111/j.1365-2125.2008.03229.x

• Molokhia M, McKeigue P, Curcin V, Majeed A. Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991-2006. 2008. PLoS ONE 3(6): e2522. doi:10.1371/journal.pone.0002522